Clinical Trial Update: A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection [Phase 1]

View source ↗

Summary

Phase 1 pediatric trial evaluating sulbactam-durlobactam for Acinetobacter baumannii-calcoaceticus complex infection (ABC) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii-calcoaceticus Complex Infection

Drugs mentioned

• Sulbactam-durlobactam (sulbactam-durlobactam)

Snippet

Sponsor: Innoviva Specialty Therapeutics | Conditions: Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | Phase 1 | Status: RECRUITING